Physiopathogenèse et traitement des maladies du foie (HEPAREG)
-
Laboratory supervisorsUniversité Paris-Saclay, Inserm
Laboratory presentation
The goal of the Physiopathogenesis and Treatment of Liver Diseases Unit is to develop translational research in hepatic pathologies on two major themes: hepatic cancers on the one hand and hepatitis (including viral) on the other hand with the will to propose innovative therapies. It is made up of renowned researchers and clinicians as well as ATRs who make the bridge between the laboratory and the patient's bed. The unit is very involved in international clinical trials for the management of hepatic carcinomas and hepatitis. Furthermore, it benefits from the equipment provided by the Lwoff Institute technical platform and the Hepatinov DHU experts network.
The 16 latest publications
Title | Authors | Publication date | Source |
---|---|---|---|
Monkeypox: Proposals for care in pregnancy | Christelle Vauloup-Fellous | 05/01/23 | Gynecologie Obstetrique Fertilite et Senologie |
Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood | Emmanuel Jacquemin | 05/01/23 | Journal of Hepatology |
Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma | Catherine Guettier, Didier Samuel, Olivier Rosmorduc | 04/01/23 | Cancer Chemotherapy and Pharmacology |
Impact of variants of SARS-CoV-2 on obstetrical and neonatal outcomes | Christelle Vauloup-Fellous, D. Luton, A. Benachi, A. J. Vivanti | 04/01/23 | Journal of Gynecology Obstetrics and Human Reproduction |
Augmented reality in liver surgery, where we stand in 2023 | Eric Vibert, Nicolas Golse | 04/01/23 | Journal of Visceral Surgery |
The protection quest is a primary key to sharing the neutralizing antibody response to cover against all emerging VOCs based on BIV1-CovIran studies | Mehdi Razazian | 03/01/23 | Heliyon |
Microencapsulated Hepatocytes Differentiated from Human Induced Pluripotent Stem Cells: Optimizing 3D Culture for Tissue Engineering Applications | Marwa Hussein, Nassima Benzoubir, J. C. Duclos-Vallée, Anne Dubart-Kupperschmitt, Antonietta Messina | 03/01/23 | Cells |
Diagnosis and Outcomes of Late-Onset Wilson's Disease: A National Registry-Based Study | Rodolphe Sobesky | 02/01/23 | Movement Disorders |
High levels of HPV16-L1 antibody but not HPV16 DNA load or integration predict oropharyngeal patient outcome: The Papillophar study | Élise Jacquin | 02/01/23 | Clinical and Experimental Medicine |
Indocyanine green fluorescence patterns of hepatocellular carcinoma correlate with pathological and molecular features | Mylène Sebagh, Christophe Desterke, Cyrille Feray, Didier Samuel, Olivier Rosmorduc, Eric Vibert, Nicolas Golse | 02/01/23 | HPB |
Nodular Regenerative Hyperplasia Is Not a Rare Condition after Liver Transplantation: Incidence, Predictive Factors, and Impact on Survival | Ilias Kounis, Mylène Sebagh, Valérie Cailliez, Bruno Roche, Eleonora De Martin, Rodolphe Sobesky, Catherine Guettier, Marc Antoine Allard, Nicolas Golse, Daniel Azoulay, Eric Vibert, J. C. Duclos-Vallée, Cyrille Feray, Didier Samuel, Audrey Coilly | 02/01/23 | Transplantation |
Molecular Mechanisms of Hepatotoxicity | Antonietta Messina, J. C. Duclos-Vallée | 02/01/23 | International Journal of Molecular Sciences |
Validation of a SARS-CoV-2 Surrogate Virus Neutralization Test in Recovered and Vaccinated Healthcare Workers | Lina Mouna, Mehdi Razazian, Sandra Duquesne, Anne Marie Roque-Afonso, Christelle Vauloup-Fellous | 02/01/23 | Viruses |
Sensitivity Analysis of a Mathematical Model Simulating the Post-Hepatectomy Hemodynamics Response | Nicolas Golse, Alexandre Joosten, Eric Vibert | 01/01/23 | Annals of Biomedical Engineering |
Hepatopulmonary syndrome | A. Sayadi, L. Duhaut, Audrey Coilly | 01/01/23 | Revue de Medecine Interne |
Maternal and congenital toxoplasmosis in Mayotte: Prevalence, incidence and management | Christelle Vauloup-Fellous | 01/01/23 | PLoS Neglected Tropical Diseases |
Number of publications of the laboratory by scientific field (2016-2021)
Every paper can be classified in one or more scientific fields. The figure below shows the lab's number of publications in each scientific field, according to the ASJC classification (Elsevier)